CTIS.eu › Cities › Italy › Parma
Parma
Italy
201 total trials
76 recruiting
2024-511397-70-00
4
2024-05-06
metastatic renal cell carcinoma (mRCC)
2023-503317-29-00
5
2024-04-12
Metastatic renal cell carcinoma (mRCC)
2023-506714-43-00
4
2024-03-15
ALK positive Non-Small Cell Lung Cancer
2023-506662-31-00
4
2024-02-28
Gastric or gastroesophageal cancer
2022-501453-36-00
5
2024-02-23
Breast cancer
2023-503708-10-00
5
2024-02-20
Locally advanced or metastatic breast cancer
2023-503865-48-00
4
2024-02-16
Locally Advanced or Metastatic Non-Small Cell Lung Cancer
2022-502980-39-00
5
2024-01-25
Estrogen receptor (ER)-positive, HER2-negative advanced breast cancer
2022-503114-23-00
3
2023-12-19
Breast Cancer
2022-500495-65-00
5
2023-12-06
Haemophilia
2022-502159-78-00
5
2023-12-06
Chronic Spontaneous Urticaria
2023-510431-11-00
4
2023-07-21
Chronic Lymphocytic Leukemia
2022-501894-37-00
4
2023-03-02
prostate cancer
2022-502140-13-00
6
2023-01-11
Atrial fibrillation
Acute coronary syndrome
Chronic coronary syndrome
2022-500783-35-00
5
2022-12-06
Acute Myeloid Leukemia
2022-500470-33-00
5
2022-11-14
Haemophilia
2023-510384-36-00
5
2022-09-13
Newly Diagnosed Multiple Myeloma
2024-511246-39-00
1
2021-07-27
Solid tumours with HER2 aberrations
2023-508922-83-00
10
2021-03-17
Advanced Non-Small Cell Lung Cancer
2024-510579-40-00
9
2020-10-07
Rhabdoyosarcoma
2024-518623-30-00
6
2020-10-01
metastatic castration resistant prostate cancer without mutations of B
2023-508101-24-00
5
2019-08-01
Lymphoblastic lymphoma
2024-515686-34-00
4
2018-11-16
BRCA-related metastatic breast cancer
2022-501254-10-00
5
2018-08-24
Advanced tumors
Showing 73–96 of 201 trials